Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px
All >

News > North America

Please find below news about the United States and Canada as well as about organisations from these countries.

Total search results: 5293 | Ordered by Date (descending)
1 2 3 ... 51 52 53  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Ginkgo Bioworks Inc.. (9/27/23). "Press Release: Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer". Boston, MA. 2023-09-27
Twist Bioscience Corporation. (9/27/23). "Press Release: Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases". South San Francisco, CA & Rafael, CA & Barcelona. 2023-09-27
Novo Nordisk A/S. (9/25/23). "Press Release: Valo Health and Novo Nordisk to Collaborate to Discover and Develop Novel Treatments for Cardiometabolic Diseases Using Human Data and Artificial Intelligence". Bagsværd & Boston, MA. 2023-09-25
Rentschler Biopharma SE. (9/19/23). "Press Release: Rentschler Biopharma Appoints Benedikt von Braunmuehl as Chief Executive Officer". Laupheim, Stevenage & Milford, MA. 2023-09-19
Scinai Immunotherapeutics Ltd.. (9/19/23). "Press Release: Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering". Jerusalem. 2023-09-19
BenevolentAI. (9/18/23). "Press Release: BenevolentAI Welcomes Christina Busmalis as its New Chief Revenue Officer". London. 2023-09-18
Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan. 2023-09-18
Broken String Biosciences Ltd.. (9/18/23). "Press Release: Broken String Biosciences Closes $15M Series A Funding Round". Cambridge. 2023-09-18
Scinai Immunotherapeutics Ltd.. (9/15/23). "Press Release: Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering". Jerusalem. 2023-09-15
ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY. 2023-09-12
Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. 2023-09-11
Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen. 2023-09-11
Scinai Immunotherapeutics Ltd.. (9/11/23). "Press Release: Scinai Immunotherapeutics Ltd. to Participate This Week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston". Jerusalem. 2023-09-11
Verge Analytics, Inc. (d/b/a Verge Genomics). (9/8/23). "Press Release: Verge Genomics Announces Artificial Intelligence-enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases". South San Francisco, CA. 2023-09-08
Mariana Oncology Inc.. (9/7/23). "Press Release: Mariana Oncology Announces $175 Million Series B Financing". Watertown, MA. 2023-09-07
Corteria Pharmaceuticals S.A.S.. (9/7/23). "Press Release: Corteria Pharmaceuticals Announces a €65M ($71M) Financing to Advance Transformational Medicines in Cardiovascular Diseases". Paris. 2023-09-07
Agilent Technologies Inc.. (9/5/23). "Press Release: Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group". Santa Clara, CA. 2023-09-05
Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA. 2023-09-05
Exscientia plc. (8/31/23). "Press Release: Exscientia to Present at Upcoming Investor Conferences in September". Oxford. 2023-08-31
Optibrium Ltd.. (8/31/23). "Press Release: Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering". Cambridge. 2023-08-31
Bayer AG. (8/30/23). "Press Release: Strong Commitment to Modern Crop Protection Made in Europe. Bayer to Invest EUR 220 Million in New R&D Facility at Its Monheim Site". Monheim. 2023-08-30
Golgi Neurosciences S.r.l.. (8/29/23). "Press Release: Golgi Neurosciences Partners with CDD Vault to Drive Innovation in Neurodegenerative Disease Treatment". Milano & San Francisco, CA. 2023-08-29
Bayer AG. (8/29/23). "Press Release: Gene Editing – Pairwise and Bayer Start New Five-year Multi-million Dollar Collaboration to Further Advance Short-stature Corn". Durham, NC & Monheim. 2023-08-29
NanoString Technologies, Inc.. (8/28/23). "Press Release: NanoString Appoints Todd Garland as Chief Commercial Officer". Seattle, WA. 2023-08-28
Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC. 2023-08-28
Illumina, Inc.. (8/28/23). "Press Release: Illumina to Webcast Upcoming Investor Conference". San Diego, CA. 2023-08-28
Synthego Corporation. (8/24/23). "Press Release: Synthego and Expand Strategic Partnership to Build a Platform for the Development of Safer and More Efficient Genetic Engineering of Human Cells for Cell Therapies". Redwood City, CA & Cambridge. 2023-08-24
AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal. 2023-08-23
Agenus Inc.. (8/23/23). "Press Release: Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers". Lexington, MA. 2023-08-23
BlueRock Therapeutics LP. (8/23/23). "Press Release: BlueRock’s Phase I Study with Bemdaneprocel in Patients with Parkinson’s Disease Meets Primary Endpoint". Wuppertal. 2023-08-23
Rapport Therapeutics, Inc.. (8/23/23). "Press Release: Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform". Boston, MA & San Diego, CA. 2023-08-23
AlphaSense Inc.. (8/23/23). "Press Release: AlphaSense Continues Global Expansion in Asia Pacific with New Regional Hub in Singapore". New York, NY. 2023-08-23
Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. 2023-08-23
Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen. 2023-08-17
Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA. 2023-08-17
Pieris Pharmaceuticals, Inc.. (8/17/23). "Press Release: Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific". Boston, MA. 2023-08-17
Novo Nordisk A/S. (8/10/23). "Press Release: Novo Nordisk to Acquire Inversago Pharma to Develop New Therapies for People Living with Obesity, Diabetes and other Serious Metabolic Diseases". Bagsværd & Montreal. 2023-08-10
Alltrna. (8/9/23). "Press Release: Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease". Cambridge, MA. 2023-08-09
IO Biotech, Inc.. (8/7/23). "Press Release: IO Biotech, Inc. Announces $75 Million Private Placement Financing". New York, NY. 2023-08-07
Gracell Biotechnologies Inc.. (8/7/23). "Press Release: Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors". San Diego, CA, Suzhou & Shanghai. 2023-08-07
Lena Biosciences, Inc.. (8/7/23). "Press Release: Lena Biosciences Appoints Dr. Eckhard von Keutz to Its Business Advisory Board and Science Advisory Board". 2023-08-07
3D Systems, Inc.. (8/7/23). "Press Release: 3D Systems & Theradaptive Establish Commercial Partnership to Advance Orthopedic & Soft Tissue Repair Using Breakthrough Regenerative Therapeutics". Rock Hill, SC & Frederick, MD. 2023-08-07
NeuBase Therapeutics, Inc.. (8/3/23). "Press Release: NeuBase Therapeutics to Explore Strategic Alternatives". Pittsburgh, PA. 2023-08-03
BiondVax Pharmaceuticals Ltd.. (8/1/23). "Press Release: Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules". Jerusalem. 2023-08-01
Sygnature Discovery Ltd.. (7/31/23). "Press Release: Sygnature Discovery Accelerates Global Growth with Major North American Acquisition". 2023-07-31
Biogen Inc.. (7/28/23). "Press Release: Biogen to Acquire Reata Pharmaceuticals". Cambridge, MA & Plano, TX. 2023-07-28
Revvity, Inc.. (7/27/23). "Press Release: Revvity Signals Software and Scitara Expand Strategic Relationship to Accelerate Laboratory Digital Transformation". Waltham, MA. 2023-07-27
Kriya Therapeutics, Inc.. (7/26/23). "Press Release: Kriya Announces $150 Million Addition to Its Series C, Bringing Total Round to over $430 Million to Further Its Mission of Delivering Gene Therapies for Prevalent Diseases". Palo Alto, CA & Research Tr 2023-07-26
Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo. 2023-07-26
Immatics N.V.. (7/24/23). "Press Release: Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb". Tübingen & Houston, TX. 2023-07-24
Roche. (7/24/23). "Press Release: Roche Enters Partnership with Alnylam to Co-develop and Co-commercialise RNAi Therapeutic Zilebesiran to Treat Hypertension in Patients with High Cardiovascular Risk". Basel. 2023-07-24
Epigenomics AG. (7/24/23). "Press Release: Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets". Berlin. 2023-07-24
ADC Therapeutics S.A.. (7/20/23). "Press Release: ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of Zynlonta (loncastuximab tesirine-lpyl) and Rituximab in Unfit or Frail Previously Untreated DLBCL Patients". Lausanne. 2023-07-20
Organomation. (7/20/23). "Press Release: Organomation Partners with Orange Science to Distribute Sample Concentrators in Japan". 2023-07-20
Tillotts Pharma AG. (7/20/23). "Press Release: Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis". Montréal, Munich & Rheinfelden. 2023-07-20
Argenx SE. (7/18/23). "Press Release: Argenx Raises $1.1 Billion in Gross Proceeds in a Global Offering". Amsterdam. 2023-07-18
Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA. 2023-07-18
Bicycle Therapeutics plc. (7/18/23). "Press Release: Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridg 2023-07-18
Pieris Pharmaceuticals, Inc.. (7/18/23). "Press Release: Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring". Boston, MA. 2023-07-18
Novartis AG. (7/17/23). "Press Release: Novartis Builds on Neuroscience Pipeline and xRNA Platform Capabilities with Acquisition of DTx Pharma". Basel. 2023-07-17
Atavistik Bio Inc.. (7/17/23). "Press Release: Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer". Cambridge, MA. 2023-07-17
Argenx SE. (7/17/23). "Press Release: Argenx Announces Launch of Proposed Global Offering". Amsterdam. 2023-07-17
Galmed Pharmaceuticals Ltd.. (7/14/23). "Press Release: Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering". Tel Aviv. 2023-07-14
Revvity, Inc.. (7/13/23). "Press Release: Revvity Establishes Scientific Centre of Excellence for Genomic Insight in Cambridge". Cambridge. 2023-07-13
Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. 2023-07-12
Merck KGaA. (7/12/23). "Press Release: Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA". Darmstadt. 2023-07-12
Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA. 2023-07-12
Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg. 2023-07-11
Abivax S.A.. (7/11/23). "Press Release: Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors". Paris. 2023-07-11
Ramarketing & PR Ltd.. (7/11/23). "Press Release: Ramarketing Announces North American Expansion". 2023-07-11
Crossbow Therapeutics, Inc-. (7/11/23). "Press Release: Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies that Mimic T-Cell Receptors to Treat Cancer". Cambridge, MA. 2023-07-11
Gamma Biosciences. (6/30/23). "Press Release: Univercells Technologies Acquired by Donaldson Company". Menlo Park, CA. 2023-06-30
Donaldson Company, Inc.. (6/29/23). "Press Release: Donaldson Acquires Univercells Technologies, Broadens Life Sciences Reach". Minneapolis, MN. 2023-06-29
BioNTech SE. (6/29/23). "Press Release: BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC". Mainz & Rockville, MD. 2023-06-29
Eli Lilly and Company. (6/29/23). "Press Release: Lilly to Acquire Sigilon Therapeutics". Indianapolis, IN & Cambridge, MA. 2023-06-29
Synthego Corporation. (6/28/23). "Press Release: Synthego and ATCC Enter Alliance for Cutting-Edge Gene Editing of Mammalian and Mouse Cell Lines". Redwood City, CA. 2023-06-28
MoonLake Immunotherapeutics AG. (6/28/23). "Press Release: MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares". Zug. 2023-06-28
Helmholtz-Zentrum für Infektionsforschung (HZI. (6/27/23). "Press Release: Geneticist Josef Penninger Becomes New Scientific Director of the Helmholtz Centre for Infection Research". 2023-06-27
AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne. 2023-06-27
MoonLake Immunotherapeutics AG. (6/26/23). "Press Release: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering". Zug. 2023-06-26
MoonLake Immunotherapeutics AG. (6/25/23). "Press Release: MoonLake Immunotherapeutics Achieves Landmark Milestone with Positive Phase 2 Results for Nanobody Sonelokimab in Hidradenitis Suppurativa". Zug. 2023-06-25
Bicycle Therapeutics plc. (6/23/23). "Press Release: Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer". Cambridge & Boston, MA. 2023-06-23
Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA. 2023-06-23
SareptaTherapeutics, Inc.. (6/22/23). "Press Release: Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy". Cambridge, MA. 2023-06-22
Memo Therapeutics AG. (6/22/23). "Press Release: Memo Therapeutics AG Starts U.S. Pivotal Phase II/III Clinical Trial with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren. 2023-06-22
Lunaphore Technologies S.A.. (6/22/23). "Press Release: Lunaphore to Get Acquired by Bio-Techne". Tolochenaz & Minneapolis, MN. 2023-06-22
SandboxAQ. (6/22/23). "Press Release: SandboxAQ Announces Biopharma Molecular Simulation Division to Speed Life-Saving Drugs to Patients Through AI and Quantum Solutions". Palo Alto, CA. 2023-06-22
Pieris Pharmaceuticals, Inc.. (6/21/23). "Press Release: Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study". Boston, MA. 2023-06-21
MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon. 2023-06-21
Eli Lilly and Company. (8/20/23). "Press Release: Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology". San Francisco, CA. 2023-06-20
Delve Bio. (8/20/23). "Press Release: Delve Bio Launches to Commercialize its Metagenomic Sequencing Platform for Infectious Disease Diagnosis". San Francisco, CA. 2023-06-20
Upstream Bio (US). (6/20/23). "Press Release: Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases". Allschwil. 2023-06-20
Mainz Biomed N.V.. (6/15/23). "Press Release: Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference". Mechelen. 2023-06-15
Theradaptive, Inc.. (6/15/23). "Press Release: Theradaptive Closes $26 Million Series A Investment Round". Frederick, MD. 2023-06-15
Galapagos N.V.. (6/15/23). "Press Release: Galapagos Appoints Thad Huston as Chief Financial Officer and Chief Operating Officer". Mechelen. 2023-06-15
Centogene N.V.. (6/14/23). "Press Release: Centogene Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency". Cambirdge, MA, Rostock & Berlin. 2023-06-14
Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA. 2023-06-13
CRISPR Therapeutics AG. (6/13/23). "Pressemitteilung: CRISPR Therapeutics to Participate in Goldman Sachs 44th Annual Global Healthcare Conference". Zug & Cambridge, MA. 2023-06-13
Novartis AG. (6/12/23). "Pressemitteilung: Novartis Bolsters Innovative Medicines Strategy and Renal Pipeline with Agreement to Acquire Chinook Therapeutics for USD 3.2bn Upfront (USD 40 / Share)". Basel. 2023-06-12
Agilent Technologies Inc.. (6/12/23). "Press Release: Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference". Santa Clara, CA. 2023-06-12
1 2 3 ... 51 52 53  next pagenext page


Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top